XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,269 | -4.8% | 11,132 | +7.3% | 0.00% | 0.0% |
| Q2 2023 | $399,399 | -41.9% | 10,374 | -46.0% | 0.00% | -50.0% |
| Q1 2023 | $687,955 | -8.6% | 19,222 | +0.7% | 0.01% | -14.3% |
| Q4 2022 | $752,837 | +39.7% | 19,093 | +27.8% | 0.01% | +40.0% |
| Q3 2022 | $539,000 | +23.3% | 14,938 | +3.9% | 0.01% | +66.7% |
| Q2 2022 | $437,000 | +0.7% | 14,377 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $434,000 | +1.6% | 14,193 | +3.7% | 0.00% | +50.0% |
| Q4 2021 | $427,000 | +177.3% | 13,684 | +35.8% | 0.00% | +100.0% |
| Q3 2021 | $154,000 | – | 10,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |